Patients using TrumpRx.gov to purchase Novo Nordisks Wegovy and Eli Lilys Zepbound without insurance will pay about $350 per month for the injectables, and the price will be reduced to $250 per month over the next two years
The Science Behind GLP-1 Peptides Therapeutic GLP-1 peptides, such as those found in medications like Semaglutide and Tirzepatide, are designed to bind to GLP-1 receptors throughout your body

Here is how they support weight loss: Reduce appetite by calming hunger signals in the brain Slow stomach emptying so you stay full longer after meals Improve insulin response to stabilize blood sugar and energy levels Encourage smaller, more controlled portions without feeling deprived Clinical research shows strong results when paired with proper nutrition: Semaglutide 2.4 mg once weekly led to an average weight loss of around 15 percent in major trials Tirzepatide, which targets both GIP and GLP-1 receptors, produced average reductions closer to 20 percent at higher doses Progress depends on consistency, dose tolerance, and adherence to a supportive lifestyle plan With the right structure and follow-up, GLP-1 therapy shifts the body toward steady, sustainable fat loss rather than rapid rebound cycles
They evaluate the manufacturers knowledge of the risks associated with its medication, its communications with the FDA, and the adequacy of its warning labels
Increased fluid loss happens through gastrointestinal side effects
It has chicken, which ups the protein content, helping to keep you satisfied even when you only eat a small portion